Showing 7871-7880 of 8648 results for "".
- Devlyn Optical Partnering with Eyenuk to Offer Diabetic Retinopathy Screeninghttps://modernod.com/news/devlyn-optical-partnering-with-eyenuk-to-offer-diabetic-retinopathy-screening/2477858/Eyenuk and Devlyn Optical, an optical retailer with over 1,000 stores in Mexico, Guatemala, El Salvador, and the US, announced that they will collaborate to pilot diabetic retinopathy (DR) screening services at Devlyn
- Re-vana Therapeutics Raises $3.25 Million in Pre-Series A Financinghttps://modernod.com/news/re-vana-therapeutics-raises-3-25-million-in-pre-series-a-financing/2477857/Re-Vana Therapeutics, a privately-held specialty therapeutic and drug delivery company developing sustained-release therapeutics for significant sight-threatening ocular diseases, announced that it has closed $3.25 mi
- CMS Increases Penalties Following Nearly 26K COVID-19 Nursing Home Deathshttps://modernod.com/news/cms-increases-penalties-following-nearly-26k-covid-19-nursing-home-deaths/2477852/The Trump administration has increased enforcement of states and nursing homes that have been repeat offenders for not following infection control practices, according to a FierceHealthcare
- Nicox Initiates First Phase 3 Trial of NCX 470 in Glaucomahttps://modernod.com/news/nicox-initiates-first-phase-3-trial-of-ncx-470-in-glaucoma/2477855/Nicox announced the initiation of the first phase 3 clinical trial, Mont Blanc, evaluating NCX 470 for the lowering of IOP in patients with open-angle glaucoma or ocular hypertension, by enrolling the first 12 patients. NCX 470 is the company’s novel, second-generation nitric oxide (NO)-donating
- Quest Diagnostics’ Self-Collection COVID-19 Test Kit Gets FDA Nod For Emergency Usehttps://modernod.com/news/quest-diagnostics-self-collection-covid-19-test-kit-gets-fda-nod-for-emergency-use/2477851/Quest Diagnostics received emergency use authorization for its self-collection COVID-19 test kit from the FDA, according to a FierceHealthcare report. The co
- Ocugen to Discontinue Phase 3 oGVHD Trialhttps://modernod.com/news/ocugen-to-discontinue-phase-3-ogvhd-trial/2477849/Ocugen announced the decision to discontinue the phase 3 trial of OCU300 for ocular Graft vs. Host Disease (oGVHD). The decision to stop the trial is based on results of a pre-planned interim sample size analysis conducted by an independent data monitoring committee, which indicated
- Expert: Hospitals Should Prepare For Pent-Up Demand From Non-COVID-19 Patientshttps://modernod.com/news/expert-hospitals-should-prepare-for-pent-up-demand-from-non-covid-19-patients/2477848/While much of the focus has been on “flattening the curve” when it comes to COVID-19, experts warn hospitals should be prepared for another potential surge: pent-up demand for deferred care, according to a FierceHealthcare
- In-Person ESCRS and Euretina Meetings Cancelled; Virtual Meetings Plannedhttps://modernod.com/news/escrs-and-euretina-meetings-cancelled-virtual-meetings-planned/2477843/Due to the COVID-19 pandemic, the in-person ESCRS and Euretina meetings, scheduled to take place in Amsterdam in October, have been cancelled. Instead, the 38th Congress of the ESCRS and the 20th Euretina Congress will be held in a virtual format. In a joint letter to their memberships, ES
- Here Are 6 Factors to Consider When Reopening Practiceshttps://modernod.com/news/here-are-6-factors-to-consider-when-reopening-practices/2477841/As thousands of physicians are working to get their practices up and running again many are thinking about safety measures to keep patients and employees safe. But what about potential medical malpractice risks and privacy protocols? As stay-at-home restrictions are relaxed, physician practices a
- Ophthalmologist Shares Experience Implementing Drive-Through IOP Checks Into Practicehttps://modernod.com/news/ophthalmologist-shares-experience-implementing-drive-through-iop-checks-into-practice/2477836/While many eye care practices remain open only for emergent and urgent care, and others slowly reopening with many patients staying at home during the COVID-19 pandemic, providers are exploring alternate ways to maintain the health of patients with chronic conditions such as glaucoma. One intrigu